<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Village Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where The Village Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0606020V0&amp;denomIds=6.6.2&amp;selectedTab=summary">Zoledronic acid</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Bisphosphonates and other drugs</td>
      <td>581</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>65.11</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0606020V0AAADAD&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Zoledronic acid 4mg/100ml infusion : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0606020V0AAABAB&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Zoledronic acid 4mg/5ml solution for infusion vials : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1302010N0&amp;denomIds=13.2.1&amp;selectedTab=summary">Paraffin soft white</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>13</td>
      <td>Emollients</td>
      <td>210</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>10.82</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1302010N0AAAAAA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin solid : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=130400000&amp;denomIds=13.4&amp;selectedTab=summary">Other topical corticosteroid preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Topical corticosteroids</td>
      <td>560</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>9.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=130400000AABLBL&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Propylene glycol 40% in Clobetasol 0.05% cream : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1307000K0&amp;denomIds=13.7&amp;selectedTab=summary">Podophyllotoxin</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Preparations for warts and calluses</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.05</td>
      <td>0.14</td>
      <td>6.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1307000K0AAAAAA&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Podophyllotoxin 0.5% solution : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0212000D0&amp;denomIds=2.12&amp;selectedTab=summary">Bezafibrate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>260</td>
      <td>Lipid-regulating drugs</td>
      <td>9130</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0212000D0AAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Bezafibrate 400mg modified-release tablets : 249</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0212000D0BBABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Bezalip Mono 400mg modified-release tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0212000D0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Bezafibrate 200mg tablets : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Village Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0410010A0&amp;denomIds=4.10.1&amp;selectedTab=summary">Acamprosate calcium</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Alcohol dependence</td>
      <td>4</td>
      <td>0.00</td>
      <td>0.83</td>
      <td>0.31</td>
      <td>-2.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1307000M0&amp;denomIds=13.7&amp;selectedTab=summary">Salicylic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Preparations for warts and calluses</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.69</td>
      <td>0.31</td>
      <td>-2.20</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0202010P0&amp;denomIds=2.2.1&amp;selectedTab=summary">Indapamide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>152</td>
      <td>Thiazides and related diuretics</td>
      <td>1432</td>
      <td>0.11</td>
      <td>0.42</td>
      <td>0.16</td>
      <td>-1.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0202010P0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 2.5mg tablets : 100</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0202010P0AAADAD&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 1.5mg modified-release tablets : 52</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=1105000B0&amp;denomIds=11.5&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Mydriatics and cycloplegics</td>
      <td>2</td>
      <td>0.00</td>
      <td>0.72</td>
      <td>0.38</td>
      <td>-1.91</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGqElEQVR4nO3dSYgcVRzH8W9lsjmJW4x6UGJhTETUxBWNew5RoXCLBkURkYDGRDx4qtxdChcQBRXBJR4UlZiglEGJW4wYQYMLHtygonGLKEr29e/h1TidTk9muru6X9fU7wNF93SGql+6+zdVXVPvTWBmiEg1jPEdQES6R4UXqRAVXqRCVHiRClHhRSpEhRepEBVepEJUeJEKUeFFKkSFF6mQ9gofBLouV6RExvoOICJDC+N0KnAzcDowE5iQJdH5ra5PhRfpQWGcTgeWAvOAl4A3ge+Ane2sN2hrtFwQGGZBOwFEZFAYp2OAxcC9wH3AS1kS7Shq/drDi/SIME6PAl4B/gHOy5Loz6K3obP0Ij0gP4T/CFgOLOhE2UF7eBHvwjg9F7dnvztLorc6uS0VXsSjME5nAa/i9uqfdXp7OqQX8SSM0xnASuDWbpQdVHgRL8I4nQakwF1ZEq3t1nZVeJEuC+P0WGAVsDRLore7uW0VXqSLwjg9Alf2h7IkWt7t7avwIl0Sxukk3GH881kSLfORQYUX6YIwTicAK4BVWRI94SuHCi/SYWGcjgVeBr4E7veZRdfSi3RQfm38C8B2YFGWRF6HlOvCG5EOCeM0AB4HxgG3+y47qPAiHZGX/UHgBGB+lkR7PUcCVHiRwuVlT4BZuLLv9hzpfyq8SIHysj8MnAJcV+RY9iKo8CIFCeN0HPA0MAW3Z29rdppO0K/lRAoQxulk4A3cFFQ39GLZQYUXaVs+6u0jYA2wpFdO0DWiQ3qRNoRxOh94FDd5Reo7z3BUeJEWhHE6BXgEOBWYmyVR5jfRyKjwIk3Ir5y7EXeJ7JPAHVkS7fGbauRUeJERyH/ddiVu6uifgHlZEv3oN1Xz2i58GKe/AfuAv4EfgG9xgwQ+ATb0wuWEIq3Kh7TeAiwB/gAWZ0n0qd9UrStk8EwYp33AUcBJwMnAWcAF+WOrcX81Y3WWRFvbTizSYfkkFZcD1wMX4uadeypLom+8BitAR0fLhXF6OHAFcBUwF7fnfwNYmSXRH61vWKQYYZz2AzOAM4AzgUuAI4H3cHPEv9urv1NvRdeGx+ZjgucA1wDXAj8DrwGvZ0n0e+shpOryz9f9wORhlkOBY4BpuEEtx+EulPkR+CJf1pbljHsrvIyHz1+gc4AFwHxgI678y1X+0St/3ccDk/Jlcs392sdqC3qwAk/CXTxmwDZgy0GWzfntX8CGfPm1TGfYi+B9Aoz8TXA2g+XfBLwNvAN8VrUXpB35NEq1Ram97ceVbVzNbe39sUBfi8uYBo9NYLDE/cDA+2QXsHWIZaCUI1k2A9uyJNpXwFNXGd4LXysv/2m4P5E7Dze8cB3u89R64KvRcOIvjNPxDO6havdyzdyvLfT4fNU72X9vVnu7DVe23Q1udwN7gL0tLPuGeHwng0VWMXtETxW+XhinE3FnSS/FnVSZBezAfdb6GnceYCPwC7CxyB8G+ciniTRXwOG+tw93+LkbV8SBQjS6P5J/3wxsyZJoV1H/bxnderrwjYRxOhWYjbuk8fia5Thcqfbi9mYDBdmOK1mtMbhDzol1S1/N9+7B/XA5WOmaKes2fTwR30pX+OHklz72M7hXPYTBz48DDFfm2mWnCimj3agrvIgMra3x8AHcWVSQbgiC4A7fGZpVtsxlywvly9xO3nYnwCjVE0X58kL5MpctL5Qvs7fCi0iJqPAiFdJu4Z8pJEX3lC0vlC9z2fJC+TK3nLe9s/QiUio6pBepkKZmvAmC4BLcxBabzOy5IAjmA9OBH8xsRScCtqtB5ttwV+mtMrP3/aY7UH3e/LGngRfMbJ3XcENo8BxfjBsKvc7M1vhNd6AGeRfixiVgZo95DTeEIAguAxaZ2U351wuBY4EPzezjka6n2T38HDNLgKPzr2eY2cPAzCbX0037ZTazZbi/DnKi11RD2y9v/kP1A6+Jhlf/vrgad0lzrw6Yqc/bhyvPJn+RDs7MPsCNIRkw1cweAC5qZj3NFr7+A38ZTgDslzEIgknAQuBFP3GGVf+czsK9qBd6yDJS9ZkPM7MncNNE9aIDxlaY2VLc0WpZtNS9pk7a5YdCc3ATVq7HzRoyHfjezFa2EqDTGmS+BzfZ5moz+8Rntkbq85rZ5/nh3I4eP6Svf1+EwL9m9qzHaA01yHspbrzFZjPryTP2QRDMxs2Yuw63s5qHOypZ08whvc7Si1SIztKLVIgKL1IhKrxIhajwIhWiwotUiAovUiEqvEiFqPAiFaLCi1SICi9SISq8SIX8BysPfPcDJCYpAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0607010C0&amp;denomIds=6.7.1&amp;selectedTab=summary">Cabergoline</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Bromocriptine and other dopaminergic drugs</td>
      <td>15</td>
      <td>0.40</td>
      <td>0.86</td>
      <td>0.27</td>
      <td>-1.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C81050&amp;numIds=0607010C0AAAAAA&amp;denomIds=6.7.1&amp;selectedTab=summary" target="_blank">Cabergoline 500microgram tablets : 6</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>